All Type of News
Nibec acquires approval of medical devices in Israel
As acquiring approval of medical devices in Israel, Nibec, a health care company specializing in peptide, will now be able to enter the global medical device market, including not only the U.S. and Europe, but the Mid...
MFDS to be reinforced 61 people to carry out government tasks in regard to job creation
The Ministry of Food and Drug Safety(MFDS) will increase the number of personnel by 61 to carry out government tasks in regard to job creation.
The MFDS preannounced the ‘Partial Revision Bill to the Enforcement Regu...
GC Pharm acquires approval of ‘Glargia’ referencing insulin glargine
GC Pharm(CEO Eun-Cheol Huh) announced on the 9th that the company acquired approval of ‘Glargia(insulin glargine),’ an antidiabetic biosimilar(bioequivalently tested) from the Ministry of Food and Drug Safety.
The or...
Hanmi Pharm invests KRW 150 billion into Smart Plant
“Since 2015, Hanmi Pharm has invested about KRW 150 billion into constructing the Paltan Industrial Complex Smart Plant; we are still planning to invest more to equip the plant. Literally, it is the largest facilities...
Who’s leading in entering U.S. market this year?
There is a market that Korean pharmaceutical companies are constantly knocking its door with confidence from their proud R&D results. It’s the U.S.
The U.S. medicine market is evaluated the world’s best medicine mark...
Process to regulate pharmacist students to give dosage guidance during work study program
A legal base will be created for pharmacist students working in the field to give a dosage guidance.
Liberty Korea Party Rep. Sang-Hoon Kim representatively proposed the ‘Partial Revision Bill to the Pharmaceutical A...
GSK’s antacid and antihistamine ‘Zantac Tab’
The Ministry of Food and Drug Safety(MFDS) imposed an administrative measure of 3-month import suspension from 20 March to 19 June on ‘Zantac 150mg,’ an GlaxoSmithKline’s antacid and antihistamine.
The MFDS said Glax...
“There are no legal definitions about generic drugs in Korea”
Since legal definitions about ‘generic drug’ lack in Korea, it was reported there is a limit in collecting precise information.
According to the ‘2017 Manufacturing and Management Statistics for International Organiz...
Hanmi Pharm’s incrementally modified drug ‘Esmezole’ mentioned in USP
‘Esomezol(generic name: esomeprazole strontium tetrahydrate),’ an incrementally modified drug developed by Hanmi Pharm, will be mentioned in the United States Pharmacopeia.
Pharmacopoeia, a book with legal force, is ...
Korean pharmas signed technology export agreements worth of USD 1.23 billion last year
The amount of earnings Korean pharmaceutical companies contracted by exporting technology last year was reportedly KRW USD 1.23 billion at most.
The Ministry of Health and Welfare(MOHW) researched technology exports ...
